International Experience in Determining the Cost-Effectiveness Thresholds

PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology
doi 10.17749/2070-4909.2018.11.4.073-080
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IRBIS

Related search

Cost-Effectiveness Thresholds in Global Health: Taking a Multisectoral Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Prm36 - Cost-Effectiveness and Budget Impact Thresholds in Health Technology Assessment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Irrelevance of Explicit Cost–effectiveness Thresholds When Coverage Decisions Can Be Reversed

Expert Review of Pharmacoeconomics and Outcomes Research
MedicineHealth PolicyPharmacology
2013English

Pcp63 - Determining the Optimal Cost-Effectiveness Cutoff From First Principles of Economics

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2018English

The Marginal Benefits of Healthcare Spending in the Netherlands: Estimating Cost‐effectiveness Thresholds Using a Translog Production Function

Health Economics
Health Policy
2019English

Draft National Health Policy of India and Determining Cost-Effectiveness Threshold

Journal of Basic and Clinical Pharmacy
2017English

Thresholds in the Process of International Financial Integration

Journal of International Money and Finance
EconomicsEconometricsFinance
2011English

Low-Income DSM Programs: Methodological Approach to Determining the Cost-Effectiveness of Coordinated Partnerships

1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy